Ross Allen focuses his practice on patent litigation and currently serves as a member of the firm's Diversity Council. He represents clients in the biotechnology, medical devices, computer systems, electronic devices and telecommunications industries, as well as the developing areas of social media and clean technology.
During law school, Mr. Allen served as a judicial intern for The Honorable Carl H. Ginsberg, Texas 193rd District Court and was the editor-in-chief of the SMU Science and Technology Law Review.
Prior to practicing law, Mr. Allen was a research assistant at Texas Tech University Health Sciences Center's Department of Pharmacology and Neuroscience, where he researched the effects of dioxin (TCDD) on circadian rhythms and CLOCK proteins mPER1, mPER2, and bMAL in mice and the correlating effects in humans using DNA/RNA extraction and rtPCR. Additionally, he externed at the University of Utah Health Sciences Center and the Associated Regional and University Pathologists (ARUP Laboratories) in molecular genetic pathology, where he worked in the research and development of molecular testing for human genetics, infectious diseases, hematopathology, oncology, pharmacogenetics, and histocompatibility.
Mr. Allen received the American Corporate Counsel Association's Larry Margolies Award for Public Interest Law and is involved in numerous community-based organizations.